To compare the clinical outcome of topical recombinant human epidermal growth factor and conventional saline dressing in management of diabetic foot ulcers - a randomised controlled trial
Phase 4
- Conditions
- Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
- Registration Number
- CTRI/2024/06/068922
- Lead Sponsor
- Aarupadai veedu medical College and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diabetic foot ulcer patients
Exclusion Criteria
Diabetic ulcer with gangrenous lesion and or involving underlying boneUncontrolled diabetes patients
3.Patient with hypersensitivity reactions to hEGF gel (redness, itching,Urticarial lesion, blebs)
4.Chronic non healing ulcers due to other etiologies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method